# Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management

> **NCT06996561** · PHASE2,PHASE3 · RECRUITING · sponsor: **Dr. Asma Abdus Salam** · enrollment: 263 (estimated)

## Conditions studied

- Cholecystectomy
- Hernia, Abdominal
- Appendectomy
- Open Colorectal Surgery
- Laparatomy
- Postoperative Pain
- Hysterectomy
- Cystectomy

## Interventions

- **DRUG:** Nalbuphine Injection
- **GENETIC:** Next Generation Sequencing
- **GENETIC:** whole exome sequencing

## Key facts

- **NCT ID:** NCT06996561
- **Lead sponsor:** Dr. Asma Abdus Salam
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-06-30
- **Target enrollment:** 263 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06996561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06996561, "Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06996561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*